BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 12187175)

  • 1. Estimating health care costs related to cancer treatment from SEER-Medicare data.
    Brown ML; Riley GF; Schussler N; Etzioni R
    Med Care; 2002 Aug; 40(8 Suppl):IV-104-17. PubMed ID: 12187175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obtaining long-term disease specific costs of care: application to Medicare enrollees diagnosed with colorectal cancer.
    Brown ML; Riley GF; Potosky AL; Etzioni RD
    Med Care; 1999 Dec; 37(12):1249-59. PubMed ID: 10599606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of approaches for estimating incidence costs of care for colorectal cancer patients.
    Yabroff KR; Warren JL; Schrag D; Mariotto A; Meekins A; Topor M; Brown ML
    Med Care; 2009 Jul; 47(7 Suppl 1):S56-63. PubMed ID: 19536010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of approaches for estimating prevalence costs of care for cancer patients: what is the impact of data source?
    Yabroff KR; Warren JL; Banthin J; Schrag D; Mariotto A; Lawrence W; Meekins A; Topor M; Brown ML
    Med Care; 2009 Jul; 47(7 Suppl 1):S64-9. PubMed ID: 19536016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Projections of the cost of cancer care in the United States: 2010-2020.
    Mariotto AB; Yabroff KR; Shao Y; Feuer EJ; Brown ML
    J Natl Cancer Inst; 2011 Jan; 103(2):117-28. PubMed ID: 21228314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total Medicare Costs Associated With Diagnosis and Treatment of Prostate Cancer in Elderly Men.
    Trogdon JG; Falchook AD; Basak R; Carpenter WR; Chen RC
    JAMA Oncol; 2019 Jan; 5(1):60-66. PubMed ID: 30242397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term medical-care costs related to prostate cancer: estimates from linked SEER-Medicare data.
    Stokes ME; Black L; Benedict A; Roehrborn CG; Albertsen P
    Prostate Cancer Prostatic Dis; 2010 Sep; 13(3):278-84. PubMed ID: 20212521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical Care Costs Associated With Cancer in Integrated Delivery Systems.
    Banegas MP; Yabroff KR; O'Keeffe-Rosetti MC; Ritzwoller DP; Fishman PA; Salloum RG; Lafata JE; Hornbrook MC
    J Natl Compr Canc Netw; 2018 Apr; 16(4):402-410. PubMed ID: 29632060
    [No Abstract]   [Full Text] [Related]  

  • 9. Estimating patient time costs associated with colorectal cancer care.
    Yabroff KR; Warren JL; Knopf K; Davis WW; Brown ML
    Med Care; 2005 Jul; 43(7):640-8. PubMed ID: 15970778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct economic burden of high-risk and metastatic melanoma in the elderly: evidence from the SEER-Medicare linked database.
    Davis KL; Mitra D; Kotapati S; Ibrahim R; Wolchok JD
    Appl Health Econ Health Policy; 2009; 7(1):31-41. PubMed ID: 19558193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost of care for elderly cancer patients in the United States.
    Yabroff KR; Lamont EB; Mariotto A; Warren JL; Topor M; Meekins A; Brown ML
    J Natl Cancer Inst; 2008 May; 100(9):630-41. PubMed ID: 18445825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of trends in the cost of initial cancer treatment.
    Warren JL; Yabroff KR; Meekins A; Topor M; Lamont EB; Brown ML
    J Natl Cancer Inst; 2008 Jun; 100(12):888-97. PubMed ID: 18544740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revisiting the Surveillance Epidemiology and End Results Cancer Registry and Medicare Health Outcomes Survey (SEER-MHOS) Linked Data Resource for Patient-Reported Outcomes Research in Older Adults with Cancer.
    Kent EE; Malinoff R; Rozjabek HM; Ambs A; Clauser SB; Topor MA; Yuan G; Burroughs J; Rodgers AB; DeMichele K
    J Am Geriatr Soc; 2016 Jan; 64(1):186-92. PubMed ID: 26782871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rising Economic Burden of Renal Cell Carcinoma among Elderly Patients in the USA: Part II-An Updated Analysis of SEER-Medicare Data.
    Shih YT; Xu Y; Chien CR; Kim B; Shen Y; Li L; Geynisman DM
    Pharmacoeconomics; 2019 Dec; 37(12):1495-1507. PubMed ID: 31286464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of Medicare costs in elderly beneficiaries with breast, colorectal, lung, or prostate cancer.
    Penberthy L; Retchin SM; McDonald MK; McClish DK; Desch CE; Riley GF; Smith TJ; Hillner BE; Newschaffer CJ
    Health Care Manag Sci; 1999 Jul; 2(3):149-60. PubMed ID: 10934539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient time costs associated with cancer care.
    Yabroff KR; Davis WW; Lamont EB; Fahey A; Topor M; Brown ML; Warren JL
    J Natl Cancer Inst; 2007 Jan; 99(1):14-23. PubMed ID: 17202109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National health care costs of peripheral arterial disease in the Medicare population.
    Hirsch AT; Hartman L; Town RJ; Virnig BA
    Vasc Med; 2008 Aug; 13(3):209-15. PubMed ID: 18687757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung cancer costs by treatment strategy and phase of care among patients enrolled in Medicare.
    Sheehan DF; Criss SD; Chen Y; Eckel A; Palazzo L; Tramontano AC; Hur C; Cipriano LE; Kong CY
    Cancer Med; 2019 Jan; 8(1):94-103. PubMed ID: 30575329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of including future medical care costs when estimating the costs attributable to a disease: a colorectal cancer case study.
    Etzioni R; Ramsey SD; Berry K; Brown M
    Health Econ; 2001 Apr; 10(3):245-56. PubMed ID: 11288190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten-year survival and cost following breast cancer recurrence: estimates from SEER-medicare data.
    Stokes ME; Thompson D; Montoya EL; Weinstein MC; Winer EP; Earle CC
    Value Health; 2008; 11(2):213-20. PubMed ID: 18380633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.